{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:10:44Z","timestamp":1776402644382,"version":"3.51.2"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T00:00:00Z","timestamp":1622937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00431-021-04138-4","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T08:02:27Z","timestamp":1622966547000},"page":"2379-2387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Life-threatening PPHN refractory to nitric oxide: proposal for a rational therapeutic algorithm"],"prefix":"10.1007","volume":"180","author":[{"given":"Feriel","family":"Fortas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Di Nardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadya","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-4834","authenticated-orcid":false,"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,6]]},"reference":[{"key":"4138_CR1","doi-asserted-by":"publisher","first-page":"1801916","DOI":"10.1183\/13993003.01916-2018","volume":"53","author":"EB Rosenzweig","year":"2019","unstructured":"Rosenzweig EB, Abman SH, Adatia I et al (2019) Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J 53:1801916. https:\/\/doi.org\/10.1183\/13993003.01916-2018","journal-title":"Eur Respir J"},{"key":"4138_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.niox.2019.12.003","volume":"95","author":"J Dillard","year":"2020","unstructured":"Dillard J, Perez M, Chen B (2020) Therapies that enhance pulmonary vascular NO-signaling in the neonate. Nitric Oxide 95:45\u201354. https:\/\/doi.org\/10.1016\/j.niox.2019.12.003","journal-title":"Nitric Oxide"},{"key":"4138_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00134-003-2122-3","volume":"30","author":"DJ Macrae","year":"2004","unstructured":"Macrae DJ, Field D, Mercier J-C et al (2004) Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med 30:372\u2013380. https:\/\/doi.org\/10.1007\/s00134-003-2122-3","journal-title":"Intensive Care Med"},{"key":"4138_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2018.04.005","volume":"199","author":"D Aboudi","year":"2018","unstructured":"Aboudi D, Swaminathan N, Brumberg H et al (2018) Sildenafil and Retinopathy of Prematurity in Preterm Infants with Bronchopulmonary Dysplasia. J Pediatr 199:16\u201321. https:\/\/doi.org\/10.1016\/j.jpeds.2018.04.005","journal-title":"J Pediatr"},{"key":"4138_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/NPM-16161","volume":"9","author":"S Al Omar","year":"2016","unstructured":"Al Omar S, Salama H, Al Hail M et al (2016) Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants A feasibility study. J Neonatal Perinatal Med 9:251\u2013259. https:\/\/doi.org\/10.3233\/NPM-16161","journal-title":"J Neonatal Perinatal Med"},{"key":"4138_CR6","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00246-012-0575-2","volume":"34","author":"A Avila-Alvarez","year":"2013","unstructured":"Avila-Alvarez A, Bravo-Laguna MC, Bronte LD, Cerro MJD (2013) Inhaled iloprost as a rescue therapy for transposition of the great arteries with persistent pulmonary hypertension of the newborn. Pediatr Cardiol 34:2027\u20132029. https:\/\/doi.org\/10.1007\/s00246-012-0575-2","journal-title":"Pediatr Cardiol"},{"key":"4138_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000088192","volume":"89","author":"D Bassler","year":"2006","unstructured":"Bassler D, Choong K, McNamara P, Kirpalani H (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Neonatology 89:1\u20135. https:\/\/doi.org\/10.1159\/000088192","journal-title":"Neonatology"},{"key":"4138_CR8","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1055\/s-0038-1676483","volume":"36","author":"F Berger-Caron","year":"2019","unstructured":"Berger-Caron F, Piedboeuf B, Morissette G et al (2019) Inhaled Epoprostenol for Pulmonary Hypertension Treatment in Neonates: A 12-Year Experience. Am J Perinatol 36:1142\u20131149. https:\/\/doi.org\/10.1055\/s-0038-1676483","journal-title":"Am J Perinatol"},{"key":"4138_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ppul.23503","volume":"52","author":"LK Darland","year":"2017","unstructured":"Darland LK, Dinh KL, Kim S et al (2017) Evaluating the safety of intermittent intravenous sildenafil in infants with pulmonary hypertension: safety of intermittent intravenous sildenafil in infants. Pediatr Pulmonol 52:232\u2013237. https:\/\/doi.org\/10.1002\/ppul.23503","journal-title":"Pediatr Pulmonol"},{"key":"4138_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1183\/09031936.98.12040932","volume":"12","author":"APMC De Jaegere","year":"1998","unstructured":"De Jaegere APMC, van den Anker JN (1998) Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension. Eur Respir J 12:932\u2013934. https:\/\/doi.org\/10.1183\/09031936.98.12040932","journal-title":"Eur Respir J"},{"key":"4138_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1460-9592.2006.01879.x","volume":"16","author":"D De Luca","year":"2006","unstructured":"De Luca D, Zecca E, Vento G et al (2006) Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia. Paediatr Anesth 16:597\u2013598. https:\/\/doi.org\/10.1111\/j.1460-9592.2006.01879.x","journal-title":"Paediatr Anesth"},{"key":"4138_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1460-9592.2006.02104.x","volume":"17","author":"D De Luca","year":"2007","unstructured":"De Luca D, Zecca E, Piastra M, Romagnoli C (2007) Iloprost as ?rescue? therapy for pulmonary hypertension of the neonate. Paediatr Anesth 17:394\u2013395. https:\/\/doi.org\/10.1111\/j.1460-9592.2006.02104.x","journal-title":"Paediatr Anesth"},{"key":"4138_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s40272-020-00412-4","volume":"22","author":"M El-Ghandour","year":"2020","unstructured":"El-Ghandour M, Hammad B, Ghanem M, Antonios MAM (2020) Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension in Resource-Limited Settings: Results of a Randomized, Double-Blind Trial. Pediatr Drugs 22:685\u2013693. https:\/\/doi.org\/10.1007\/s40272-020-00412-4","journal-title":"Pediatr Drugs"},{"key":"4138_CR14","first-page":"333","volume":"30","author":"N Fatima","year":"2018","unstructured":"Fatima N, Arshad S, Quddusi AI et al (2018) Comparison Of The Efficacy Of Sildenafil Alone Versus Sildenafil Plus Bosentan In Newborns With Persistent Pulmonary Hypertension. J Ayub Med Coll Abbottabad 30:333\u2013336","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"4138_CR15","doi-asserted-by":"publisher","first-page":"bcr2014204262","DOI":"10.1136\/bcr-2014-204262","volume":"2014","author":"M Gaffuri","year":"2014","unstructured":"Gaffuri M, Cristofaletti A, Mansoldo C, Biban P (2014) Acute onset of bilateral visual loss during sildenafil therapy in a young infant with congenital heart disease. BMJ Case Rep 2014:bcr2014204262. https:\/\/doi.org\/10.1136\/bcr-2014-204262","journal-title":"BMJ Case Rep"},{"key":"4138_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1055\/s-0036-1597996","volume":"34","author":"A Giaccone","year":"2017","unstructured":"Giaccone A, Zuppa A, Sood B et al (2017) Milrinone Pharmacokinetics and Pharmacodynamics in Neonates with Persistent Pulmonary Hypertension of the Newborn. Am J Perinatol 34:749\u2013758. https:\/\/doi.org\/10.1055\/s-0036-1597996","journal-title":"Am J Perinatol"},{"key":"4138_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00431-007-0531-y","volume":"167","author":"C Goissen","year":"2008","unstructured":"Goissen C, Ghyselen L, Tourneux P et al (2008) Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan. Eur J Pediatr 167:437\u2013440. https:\/\/doi.org\/10.1007\/s00431-007-0531-y","journal-title":"Eur J Pediatr"},{"key":"4138_CR18","doi-asserted-by":"publisher","first-page":"F186","DOI":"10.1136\/archdischild-2012-303294","volume":"98","author":"N Gupta","year":"2013","unstructured":"Gupta N, Kamlin CO, Cheung M et al (2013) Prostaglandin E1 use during neonatal transfer: potential beneficial role in persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed 98:F186\u2013F188. https:\/\/doi.org\/10.1136\/archdischild-2012-303294","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4138_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jpc.14571","volume":"56","author":"R Iannotta","year":"2020","unstructured":"Iannotta R, Tana M, Priolo F et al (2020) Rectal bleeding in extremely preterm infants associated with oral sildenafil therapy: A case series. J Paediatr Child Health 56:163\u2013164. https:\/\/doi.org\/10.1111\/jpc.14571","journal-title":"J Paediatr Child Health"},{"key":"4138_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12519-011-0276-6","volume":"7","author":"Y Iwamoto","year":"2011","unstructured":"Iwamoto Y, Tamai A, Kawasaki H et al (2011) Late clinical manifestations of mitral valve disease and severe pulmonary hypertension in a patient diagnosed with premature closure of foramen ovale during fetal life. World J Pediatr 7:182\u2013184. https:\/\/doi.org\/10.1007\/s12519-011-0276-6","journal-title":"World J Pediatr"},{"key":"4138_CR21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s13312-013-0263-1","volume":"50","author":"W Janjindamai","year":"2013","unstructured":"Janjindamai W, Thatrimontrichai A, Maneenil G et al (2013) Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn. Indian Pediatr 50:934\u2013938. https:\/\/doi.org\/10.1007\/s13312-013-0263-1","journal-title":"Indian Pediatr"},{"key":"4138_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/ppul.22985","volume":"49","author":"H Kahveci","year":"2014","unstructured":"Kahveci H, Yilmaz O, Avsar UZ et al (2014) Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn: Sildenafil and Iloprost in the Treatment of PH. Pediatr Pulmonol 49:1205\u20131213. https:\/\/doi.org\/10.1002\/ppul.22985","journal-title":"Pediatr Pulmonol"},{"key":"4138_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1067\/mpd.2002.129849","volume":"141","author":"LK Kelly","year":"2002","unstructured":"Kelly LK, Porta NFM, Goodman DM et al (2002) Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 141:830\u2013832. https:\/\/doi.org\/10.1067\/mpd.2002.129849","journal-title":"J Pediatr"},{"key":"4138_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ppul.23935","volume":"53","author":"F Kipfmueller","year":"2018","unstructured":"Kipfmueller F, Schroeder L, Berg C et al (2018) Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia. Pediatr Pulmonol 53:452\u2013460. https:\/\/doi.org\/10.1002\/ppul.23935","journal-title":"Pediatr Pulmonol"},{"key":"4138_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1442-200X.2012.03712.x","volume":"54","author":"Y Kodama","year":"2012","unstructured":"Kodama Y, Tao K, Ishida F et al (2012) Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan: alveolar capillary dysplasia. Pediatr Int 54:923\u2013926. https:\/\/doi.org\/10.1111\/j.1442-200X.2012.03712.x","journal-title":"Pediatr Int"},{"key":"4138_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1542\/peds.97.3.295","volume":"97","author":"GG Konduri","year":"1996","unstructured":"Konduri GG, Garcia DC, Kazzi NJ, Shankaran S (1996) Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 97:295\u2013300","journal-title":"Pediatrics"},{"key":"4138_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpedsurg.2018.10.039","volume":"54","author":"KM Lawrence","year":"2019","unstructured":"Lawrence KM, Berger K, Herkert L et al (2019) Use of prostaglandin E1 to treat pulmonary hypertension in congenital diaphragmatic hernia. J Pediatr Surg 54:55\u201359. https:\/\/doi.org\/10.1016\/j.jpedsurg.2018.10.039","journal-title":"J Pediatr Surg"},{"key":"4138_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.jpedsurg.2020.01.008","volume":"55","author":"K Le Duc","year":"2020","unstructured":"Le Duc K, Mur S, Sharma D et al (2020) Prostaglandin E1 in infants with congenital diaphragmatic hernia (CDH) and life-threatening pulmonary hypertension. J Pediatr Surg 55:1872\u20131878. https:\/\/doi.org\/10.1016\/j.jpedsurg.2020.01.008","journal-title":"J Pediatr Surg"},{"key":"4138_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pedneo.2017.02.003","volume":"59","author":"G Maneenil","year":"2018","unstructured":"Maneenil G, Thatrimontrichai A, Janjindamai W, Dissaneevate S (2018) Effect of bosentan therapy in persistent pulmonary hypertension of the newborn. Pediatr Neonatol 59:58\u201364. https:\/\/doi.org\/10.1016\/j.pedneo.2017.02.003","journal-title":"Pediatr Neonatol"},{"key":"4138_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/PCC.0b013e31824ea2cd","volume":"14","author":"PJ McNamara","year":"2013","unstructured":"McNamara PJ, Shivananda SP, Sahni M et al (2013) Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr Crit Care Med 14:74\u201384. https:\/\/doi.org\/10.1097\/PCC.0b013e31824ea2cd","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/01.PCC.0000225000.78627.EB","volume":"7","author":"A Motti","year":"2006","unstructured":"Motti A, Tissot C, Rimensberger PC et al (2006) Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy. Pediatr Crit Care Med 7:380\u2013382. https:\/\/doi.org\/10.1097\/01.PCC.0000225000.78627.EB","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000298137","volume":"99","author":"N Nakwan","year":"2011","unstructured":"Nakwan N, Nakwan N, Wannaro J (2011) Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review. Neonatology 99:32\u201337. https:\/\/doi.org\/10.1159\/000298137","journal-title":"Neonatology"},{"key":"4138_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/01.CCM.0000105309.27519.27","volume":"5","author":"C Ng","year":"2004","unstructured":"Ng C, Franklin O, Vaidya M et al (2004) Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 5:10\u201313. https:\/\/doi.org\/10.1097\/01.CCM.0000105309.27519.27","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR34","first-page":"1221","volume":"35","author":"S Patole","year":"1998","unstructured":"Patole S, Lee J, Whitehall J (1998) Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension. Indian Pediatr 35:1221\u20131224","journal-title":"Indian Pediatr"},{"key":"4138_CR35","doi-asserted-by":"publisher","first-page":"e7303","DOI":"10.1097\/MD.0000000000007303","volume":"96","author":"BY Park","year":"2017","unstructured":"Park BY, Chung S-H (2017) Treprostinil for persistent pulmonary hypertension of the newborn, with early onset sepsis in preterm infant: 2 Case reports. Medicine (Baltimore) 96:e7303. https:\/\/doi.org\/10.1097\/MD.0000000000007303","journal-title":"Medicine (Baltimore)"},{"key":"4138_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/0974-2069.58325","volume":"2","author":"R Pawar","year":"2009","unstructured":"Pawar R, Kasar P, Garekar S, Kulkarni S (2009) Use of Bosentan in neonatal post cardiac surgery pulmonary hypertension. Ann Pediatr Card 2:173. https:\/\/doi.org\/10.4103\/0974-2069.58325","journal-title":"Ann Pediatr Card"},{"key":"4138_CR37","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00431-011-1422-9","volume":"170","author":"M Radicioni","year":"2011","unstructured":"Radicioni M, Bruni A, Camerini P (2011) Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use. Eur J Pediatr 170:1075\u20131078. https:\/\/doi.org\/10.1007\/s00431-011-1422-9","journal-title":"Eur J Pediatr"},{"key":"4138_CR38","first-page":"491","volume":"58","author":"S Rugolotto","year":"2006","unstructured":"Rugolotto S, Errico G, Beghini R et al (2006) Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia. Minerva Pediatr 58:491\u2013494","journal-title":"Minerva Pediatr"},{"key":"4138_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/PCC.0000000000000077","volume":"15","author":"S Samiee-Zafarghandy","year":"2014","unstructured":"Samiee-Zafarghandy S, Smith PB, van den Anker JN (2014) Safety of Sildenafil in Infants. Pediatr Crit Care Med 15:362\u2013368. https:\/\/doi.org\/10.1097\/PCC.0000000000000077","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0022-3468(95)90751-3","volume":"30","author":"D Schranz","year":"1995","unstructured":"Schranz D, Huth R, Michel-Behnke I, Wippermann C-F (1995) Norepinephrine, enoximone, and nitric oxide for treatment of myocardial stunning and pulmonary hypertension in a newborn with diaphragmatic hernia. J Pediatr Surg 30:801\u2013804. https:\/\/doi.org\/10.1016\/0022-3468(95)90751-3","journal-title":"J Pediatr Surg"},{"key":"4138_CR41","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00383-008-2225-6","volume":"24","author":"S Shiyanagi","year":"2008","unstructured":"Shiyanagi S, Okazaki T, Shoji H et al (2008) Management of pulmonary hypertension in congenital diaphragmatic hernia: nitric oxide with prostaglandin-E1 versus nitric oxide alone. Pediatr Surg Int 24:1101\u20131104. https:\/\/doi.org\/10.1007\/s00383-008-2225-6","journal-title":"Pediatr Surg Int"},{"key":"4138_CR42","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s001340050498","volume":"23","author":"V Soditt","year":"1997","unstructured":"Soditt V, Aring C, Groneck P (1997) Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med 23:1275\u20131278. https:\/\/doi.org\/10.1007\/s001340050498","journal-title":"Intensive Care Med"},{"key":"4138_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1203\/01.PDR.0000139927.86617.B6","volume":"56","author":"BG Sood","year":"2004","unstructured":"Sood BG, Delaney-Black V, Aranda JV, Shankaran S (2004) Aerosolized PGE1: A Selective Pulmonary Vasodilator in Neonatal Hypoxemic Respiratory Failure Results of a Phase I\/II Open Label Clinical Trial. Pediatr Res 56:579\u2013585. https:\/\/doi.org\/10.1203\/01.PDR.0000139927.86617.B6","journal-title":"Pediatr Res"},{"key":"4138_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0034-1375697","volume":"226","author":"M Steiner","year":"2014","unstructured":"Steiner M, Salzer U, Baumgartner S et al (2014) Intravenous Sildenafil i. v. as Rescue Treatment for Refractory Pulmonary Hypertension in Extremely Preterm Infants. Klin Padiatr 226:211\u2013215. https:\/\/doi.org\/10.1055\/s-0034-1375697","journal-title":"Klin Padiatr"},{"key":"4138_CR45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jpeds.2009.06.012","volume":"155","author":"RH Steinhorn","year":"2009","unstructured":"Steinhorn RH, Kinsella JP, Pierce C et al (2009) Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J Pediatr 155:841\u2013847.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2009.06.012","journal-title":"J Pediatr"},{"key":"4138_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jpeds.2016.06.078","volume":"177","author":"RH Steinhorn","year":"2016","unstructured":"Steinhorn RH, Fineman J, Kusic-Pajic A et al (2016) Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial. J Pediatr 177:90\u201396.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2016.06.078","journal-title":"J Pediatr"},{"key":"4138_CR47","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s00134-003-2016-4","volume":"29","author":"C Stocker","year":"2003","unstructured":"Stocker C, Penny DJ, Brizard CP et al (2003) Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 29:1996\u20132003. https:\/\/doi.org\/10.1007\/s00134-003-2016-4","journal-title":"Intensive Care Med"},{"key":"4138_CR48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2146\/ajhp120364","volume":"70","author":"JS Stultz","year":"2013","unstructured":"Stultz JS, Puthoff T, Backes C, Nahata MC (2013) Intermittent intravenous sildenafil for pulmonary hypertension management in neonates and infants. Am J Health Syst Pharm 70:407\u2013413. https:\/\/doi.org\/10.2146\/ajhp120364","journal-title":"Am J Health Syst Pharm"},{"key":"4138_CR49","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1442-200X.2002.01597.x","volume":"44","author":"H Suzuki","year":"2002","unstructured":"Suzuki H, Sato S, Tanabe S, Hayasaka K (2002) Beraprost sodium for pulmonary hypertension with congenital heart disease. Pediatr Int 44:528\u2013529. https:\/\/doi.org\/10.1046\/j.1442-200X.2002.01597.x","journal-title":"Pediatr Int"},{"key":"4138_CR50","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/BF01957520","volume":"152","author":"M Tohyama","year":"1993","unstructured":"Tohyama M, Baba A, Tsuno T et al (1993) Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia. Eur J Pediatr 152:877\u2013879. https:\/\/doi.org\/10.1007\/BF01957520","journal-title":"Eur J Pediatr"},{"key":"4138_CR51","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5863\/1551-6776-25.7.647","volume":"25","author":"MN Turbenson","year":"2020","unstructured":"Turbenson MN, Radosevich JJ, Manuel V, Feldman J (2020) Transitioning From Intravenous to Subcutaneous Prostacyclin Therapy in Neonates With Severe Pulmonary Hypertension. J Pediatr Pharmacol Ther 25:647\u2013653. https:\/\/doi.org\/10.5863\/1551-6776-25.7.647","journal-title":"J Pediatr Pharmacol Ther"},{"key":"4138_CR52","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12887-018-1270-0","volume":"18","author":"S Iijima","year":"2018","unstructured":"Iijima S, Ueno D, Baba T, Ohishi A (2018) Hypertrophic pyloric stenosis following persistent pulmonary hypertension of the newborn: a case report and literature review. BMC Pediatr 18:290. https:\/\/doi.org\/10.1186\/s12887-018-1270-0","journal-title":"BMC Pediatr"},{"key":"4138_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ccr3.748","volume":"5","author":"R van der Lee","year":"2017","unstructured":"van der Lee R, Peels B, Koopman-Esseboom C (2017) PDE3 inhibition with enoximone as first-line therapy for severe persistent pulmonary hypertension of the newborn during neonatal transport: a case report. Clin Case Rep 5:18\u201321. https:\/\/doi.org\/10.1002\/ccr3.748","journal-title":"Clin Case Rep"},{"key":"4138_CR54","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jpeds.2015.11.050","volume":"170","author":"JP Kinsella","year":"2016","unstructured":"Kinsella JP, Steinhorn RH, Krishnan US et al (2016) Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr 170:312\u2013314. https:\/\/doi.org\/10.1016\/j.jpeds.2015.11.050","journal-title":"J Pediatr"},{"key":"4138_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000501462","volume":"116","author":"R Centorrino","year":"2019","unstructured":"Centorrino R, Shankar-Aguilera S, Foligno S, De Luca D (2019) Life-threatening extreme methemoglobinemia during standard dose nitric oxide therapy. Neonatology 116:295\u2013298. https:\/\/doi.org\/10.1159\/000501462","journal-title":"Neonatology"},{"key":"4138_CR56","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(17)30214-X","volume":"5","author":"D De Luca","year":"2017","unstructured":"De Luca D, van Kaam AH, Tingay DG et al (2017) The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med 5:657\u2013666. https:\/\/doi.org\/10.1016\/S2213-2600(17)30214-X","journal-title":"Lancet Respir Med"},{"key":"4138_CR57","doi-asserted-by":"publisher","first-page":"1801965","DOI":"10.1183\/13993003.01965-2018","volume":"54","author":"C Galambos","year":"2019","unstructured":"Galambos C, Mullen MP, Shieh JT et al (2019) Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. Eur Respir J 54:1801965. https:\/\/doi.org\/10.1183\/13993003.01965-2018","journal-title":"Eur Respir J"},{"key":"4138_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1086\/685080","volume":"6","author":"RM DiBlasi","year":"2016","unstructured":"DiBlasi RM, Crotwell DN, Shen S et al (2016) Iloprost Drug Delivery during Infant Conventional and High-Frequency Oscillatory Ventilation. Pulm Circ 6:63\u201369. https:\/\/doi.org\/10.1086\/685080","journal-title":"Pulm Circ"},{"key":"4138_CR59","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/ppul.21619","volume":"47","author":"M Piastra","year":"2012","unstructured":"Piastra M, De Luca D, De Carolis MP et al (2012) Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series. Pediatr Pulmonol 47:757\u2013762. https:\/\/doi.org\/10.1002\/ppul.21619","journal-title":"Pediatr Pulmonol"},{"key":"4138_CR60","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/sj.ijir.3900795","volume":"14","author":"A Nehra","year":"2002","unstructured":"Nehra A, Blute ML, Barrett DM, Moreland RB (2002) Rationale for combination therapy of intraurethral prostaglandin E1 and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res 14:S38\u2013S42. https:\/\/doi.org\/10.1038\/sj.ijir.3900795","journal-title":"Int J Impot Res"},{"key":"4138_CR61","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/HYPERTENSIONAHA.111.182261","volume":"59","author":"F Liang","year":"2012","unstructured":"Liang F, Yang S, Yao L et al (2012) Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries. Hypertension 59:705\u2013711. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.182261","journal-title":"Hypertension"},{"key":"4138_CR62","doi-asserted-by":"publisher","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","volume":"136","author":"HA Ghofrani","year":"2002","unstructured":"Ghofrani HA, Wiedemann R, Rose F et al (2002) Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary Hypertension. Ann Intern Med 136:515. https:\/\/doi.org\/10.7326\/0003-4819-136-7-200204020-00008","journal-title":"Ann Intern Med"},{"key":"4138_CR63","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1203\/01.PDR.0000112033.81970.C2","volume":"55","author":"LS Shekerdemian","year":"2004","unstructured":"Shekerdemian LS, Ravn HB, Penny DJ (2004) Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 55:413\u2013418. https:\/\/doi.org\/10.1203\/01.PDR.0000112033.81970.C2","journal-title":"Pediatr Res"},{"key":"4138_CR64","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/1535370213498981","volume":"238","author":"SM Knebel","year":"2013","unstructured":"Knebel SM, Elrick MM, Bowles EA et al (2013) Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3\u2032,5\u2032 monophosphate accumulation and adenosine 3\u20325\u2032 triphosphate release from human erythrocytes. Exp Biol Med (Maywood) 238:1069\u20131074. https:\/\/doi.org\/10.1177\/1535370213498981","journal-title":"Exp Biol Med (Maywood)"},{"key":"4138_CR65","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/lt.21310","volume":"14","author":"MJ Austin","year":"2008","unstructured":"Austin MJ, McDougall NI, Wendon JA et al (2008) Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension: combination therapy in PPHTN. Liver Transpl 14:287\u2013291. https:\/\/doi.org\/10.1002\/lt.21310","journal-title":"Liver Transpl"},{"key":"4138_CR66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","volume":"28","author":"B Deb","year":"2000","unstructured":"Deb B, Bradford K, Pearl RG (2000) Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 28:795\u2013799. https:\/\/doi.org\/10.1097\/00003246-200003000-00031","journal-title":"Crit Care Med"},{"key":"4138_CR67","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1183\/13993003.02044-2014","volume":"46","author":"V McLaughlin","year":"2015","unstructured":"McLaughlin V, Channick RN, Ghofrani H-A et al (2015) Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. Eur Respir J 46:405\u2013413. https:\/\/doi.org\/10.1183\/13993003.02044-2014","journal-title":"Eur Respir J"},{"key":"4138_CR68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","volume":"10","author":"S Lakshminrusimha","year":"2009","unstructured":"Lakshminrusimha S, Porta NFM, Farrow KN et al (2009) Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10:106\u2013112. https:\/\/doi.org\/10.1097\/PCC.0b013e3181936aee","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR69","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.plefa.2013.04.004","volume":"89","author":"I Gomez","year":"2013","unstructured":"Gomez I, Foudi N, Longrois D, Norel X (2013) The role of prostaglandin E2 in human vascular inflammation. Prostaglandins Leukot Essent Fat Acids 89:55\u201363. https:\/\/doi.org\/10.1016\/j.plefa.2013.04.004","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"4138_CR70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000098173","volume":"91","author":"LG Ly","year":"2007","unstructured":"Ly LG, Hawes J, Whyte HE et al (2007) The hemodynamically significant ductus arteriosus in Critically Ill Full-Term Neonates. Neonatology 91:260\u2013265. https:\/\/doi.org\/10.1159\/000098173","journal-title":"Neonatology"},{"issue":"1","key":"4138_CR71","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13054-020-2787-9","volume":"24","author":"Y Singh","year":"2020","unstructured":"Singh Y, Tissot C, Fraga MV et al (2020) International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC). Crit Care 24(1):65. https:\/\/doi.org\/10.1186\/s13054-020-2787-9","journal-title":"Crit Care"},{"key":"4138_CR72","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/jp.2016.65","volume":"36","author":"A Boet","year":"2016","unstructured":"Boet A, Jourdain G, Demontoux S, De Luca D (2016) Stroke volume and cardiac output evaluation by electrical cardiometry: accuracy and reference nomograms in hemodynamically stable preterm neonates. J Perinatol 36:748\u2013752. https:\/\/doi.org\/10.1038\/jp.2016.65","journal-title":"J Perinatol"},{"key":"4138_CR73","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3109\/14767058.2015.1077221","volume":"29","author":"M-H Gagnon","year":"2016","unstructured":"Gagnon M-H, Wintermark P (2016) Effect of persistent pulmonary hypertension on brain oxygenation in asphyxiated term newborns treated with hypothermia. J Matern Fetal Neonatal Med 29:2049\u20132055. https:\/\/doi.org\/10.3109\/14767058.2015.1077221","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"Suppl 2","key":"4138_CR74","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1038\/jp.2009.24","volume":"29","author":"EF Fernandez","year":"2009","unstructured":"Fernandez EF, Watterberg KL (2009) Relative adrenal insufficiency in the preterm and term infant. J Perinatol 29(Suppl 2):S44\u2013S49. https:\/\/doi.org\/10.1038\/jp.2009.24","journal-title":"J Perinatol"},{"key":"4138_CR75","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clp.2010.04.002","volume":"37","author":"JL Wynn","year":"2010","unstructured":"Wynn JL, Wong HR (2010) Pathophysiology and treatment of septic shock in neonates. Clin Perinatol 37:439\u2013479. https:\/\/doi.org\/10.1016\/j.clp.2010.04.002","journal-title":"Clin Perinatol"},{"key":"4138_CR76","doi-asserted-by":"publisher","first-page":"L595","DOI":"10.1152\/ajplung.00145.2011","volume":"302","author":"M Perez","year":"2012","unstructured":"Perez M, Lakshminrusimha S, Wedgwood S et al (2012) Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn. Am J Phys Lung Cell Mol Phys 302:L595\u2013L603. https:\/\/doi.org\/10.1152\/ajplung.00145.2011","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"4138_CR77","doi-asserted-by":"publisher","first-page":"117955651988891","DOI":"10.1177\/1179556519888918","volume":"13","author":"M Alsaleem","year":"2019","unstructured":"Alsaleem M, Malik A, Lakshminrusimha S, Kumar VH (2019) Hydrocortisone improves oxygenation index and systolic blood pressure in term infants with persistent pulmonary hypertension. Clin Med Insights Pediatr 13:117955651988891. https:\/\/doi.org\/10.1177\/1179556519888918","journal-title":"Clin Med Insights Pediatr"},{"key":"4138_CR78","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/PCC.0b013e31822f192b","volume":"13","author":"C Mulligan","year":"2012","unstructured":"Mulligan C, Beghetti M (2012) Inhaled iloprost for the control of acute pulmonary hypertension in children: a systematic review. Pediatr Crit Care Med 13:472\u2013480. https:\/\/doi.org\/10.1097\/PCC.0b013e31822f192b","journal-title":"Pediatr Crit Care Med"},{"key":"4138_CR79","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/01.CIR.103.4.544","volume":"103","author":"PC Rimensberger","year":"2001","unstructured":"Rimensberger PC, Spahr-Schopfer I, Berner M et al (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103:544\u2013548. https:\/\/doi.org\/10.1161\/01.CIR.103.4.544","journal-title":"Circulation"},{"key":"4138_CR80","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.200907-1126OC","volume":"182","author":"RL Keller","year":"2010","unstructured":"Keller RL, Tacy TA, Hendricks-Munoz K et al (2010) Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 182:555\u2013561. https:\/\/doi.org\/10.1164\/rccm.200907-1126OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4138_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1055\/s-2007-994352","volume":"13","author":"P Kumar","year":"1996","unstructured":"Kumar P, Kazzi N, Shankaran S (1996) Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 13:335\u2013341. https:\/\/doi.org\/10.1055\/s-2007-994352","journal-title":"Am J Perinatol"},{"key":"4138_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-3476(05)81552-5","volume":"123","author":"AA Rosenberg","year":"1993","unstructured":"Rosenberg AA, Kennaugh J, Koppenhafer SL et al (1993) Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123:109\u2013114. https:\/\/doi.org\/10.1016\/S0022-3476(05)81552-5","journal-title":"J Pediatr"},{"key":"4138_CR83","doi-asserted-by":"publisher","first-page":"e0204427","DOI":"10.1371\/journal.pone.0204427","volume":"13","author":"HTML de Costa","year":"2018","unstructured":"de Costa HTML, Costa TX, Martins RR, Oliveira AG (2018) Use of off-label and unlicensed medicines in neonatal intensive care. PLoS One 13:e0204427. https:\/\/doi.org\/10.1371\/journal.pone.0204427","journal-title":"PLoS One"},{"key":"4138_CR84","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm317123.htm [accessed on february 6, 2021]"},{"key":"4138_CR85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/clpt.2008.177","volume":"85","author":"A Mukherjee","year":"2009","unstructured":"Mukherjee A, Dombi T, Wittke B, Lalonde R (2009) Population pharmacokinetics of sildenafil in term neonates: evidence of rapid maturation of metabolic clearance in the early postnatal period. Clin Pharmacol Ther 85:56\u201363. https:\/\/doi.org\/10.1038\/clpt.2008.177","journal-title":"Clin Pharmacol Ther"},{"key":"4138_CR86","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.semperi.2015.12.004","volume":"40","author":"S Lakshminrusimha","year":"2016","unstructured":"Lakshminrusimha S, Mathew B, Leach CL (2016) Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide. Semin Perinatol 40:160\u2013173. https:\/\/doi.org\/10.1053\/j.semperi.2015.12.004","journal-title":"Semin Perinatol"},{"key":"4138_CR87","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","volume":"174","author":"P Namachivayam","year":"2006","unstructured":"Namachivayam P, Theilen U, Butt WW et al (2006) Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 174:1042\u20131047. https:\/\/doi.org\/10.1164\/rccm.200605-694OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4138_CR88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","volume":"154","author":"PM Mourani","year":"2009","unstructured":"Mourani PM, Sontag MK, Ivy DD, Abman SH (2009) Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr 154:379\u2013384.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2008.09.021","journal-title":"J Pediatr"},{"key":"4138_CR89","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpeds.2018.09.067","volume":"205","author":"JL Cohen","year":"2019","unstructured":"Cohen JL, Nees SN, Valencia GA, Rosenzweig EB, Krishnan US (2019) Sildenafil use in children with pulmonary hypertension. J Pediatr 205:29\u201334.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2018.09.067","journal-title":"J Pediatr"},{"key":"4138_CR90","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ppul.21415","volume":"46","author":"B G\u00fcrakan","year":"2011","unstructured":"G\u00fcrakan B, Kay\u0131ran P, \u00d6zt\u00fcrk N et al (2011) Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension. Pediatr Pulmonol 46:617\u2013620. https:\/\/doi.org\/10.1002\/ppul.21415","journal-title":"Pediatr Pulmonol"},{"key":"4138_CR91","doi-asserted-by":"publisher","first-page":"103764","DOI":"10.1016\/j.ejmg.2019.103764","volume":"63","author":"M Mizuno","year":"2020","unstructured":"Mizuno M, Aso K, Tsuzuki Y et al (2020) A successful treatment of tadalafil in incontinentia pigmenti with pulmonary hypertension. Eur J Med Genet 63:103764. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103764","journal-title":"Eur J Med Genet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-021-04138-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-021-04138-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:03:23Z","timestamp":1744189403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-021-04138-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,6]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1007\/s00431-021-04138-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,6]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Humbert reports personal fees from Acceleron, grants and personal fees from Actelion, grants and personal fees from Bayer, personal fees from GSK,\u00a0personal fees from Merck, personal fees from Novartis, personal fees from Astrazeneca, personal fees from Sanofi, outside the submitted work\u00a0The other authors have no conflict of interest or competing interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/Competing interests"}}]}}